TY  - GEN
AU  - De Miguel, Rosa
AU  - Rial-Crestelo, David
AU  - Domínguez-Domínguez, Lourdes
AU  - Montejano, Rocío
AU  - Esteban-Cantos, Andres
AU  - Aranguren-Rivas, Paula
AU  - Stella-Ascariz, Natalia
AU  - Bisbal, Otilia
AU  - Bermejo-Plaza, Laura
AU  - Garcia-Alvarez, Monica
AU  - Alejos, Belén
AU  - Hernando, Asunción
AU  - Santacreu-Guerrero, Mireia
AU  - Cadiñanos, Julen
AU  - Mayoral, Mario
AU  - Castro, Juan Miguel
AU  - Moreno, Victoria
AU  - Martin-Carbonero, Luz
AU  - Delgado, Rafael
AU  - Rubio, Rafael
AU  - Pulido, Federico
AU  - Arribas, José Ramón
AU  - ART-PRO, PI16/00837-PI16/00678 study group
PY  - 2020
DO  - 10.1016/j.ebiom.2020.102779
UR  - http://hdl.handle.net/20.500.12105/10862
AB  - Background: We investigated the efficacy of a switch to dolutegravir plus lamivudine in aviremic individuals without evidence of persistent lamivudine resistance-associated mutations in baseline proviral DNA population sequencing. Methods: Open-label,...
LA  - eng
PB  - Elsevier
TI  - Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).
TY  - research article
ER  -